Search Results - "SAGEBIEL, Richard W"

Refine Results
  1. 1

    Discordance in the histopathologic diagnosis of melanoma at a melanoma referral center by Shoo, B. Aika, MD, Sagebiel, Richard W., MD, Kashani-Sabet, Mohammed, MD

    “…Background Histopathologic analysis remains the gold standard for the pathologic diagnosis of melanoma. Numerous histologic criteria are used to diagnose…”
    Get full text
    Journal Article
  2. 2

    Analysis of sentinel lymph node positivity in patients with thin primary melanoma by Venna, Suraj S., MD, Thummala, Suresh, MBBS, Nosrati, Mehdi, BS, Leong, Stanley P., MD, Miller, James R., MBA, PhD, Sagebiel, Richard W., MD, Kashani-Sabet, Mohammed, MD

    “…Background A minority of patients with T1 melanoma will have a positive sentinel lymph node (SLN) biopsy (SLNB) finding. Identifying who will develop…”
    Get full text
    Journal Article
  3. 3
  4. 4

    multi-marker assay to distinguish malignant melanomas from benign nevi by Kashani-Sabet, Mohammed, Rangel, Javier, Torabian, Sima, Nosrati, Mehdi, Simko, Jeff, Jablons, David M, Moore, Dan H, Haqq, Chris, Miller, James R. III, Sagebiel, Richard W

    “…The histopathological diagnosis of melanoma can be challenging. No currently used molecular markers accurately distinguish between nevus and melanoma. Recent…”
    Get full text
    Journal Article
  5. 5

    A Multimarker Prognostic Assay for Primary Cutaneous Melanoma by Kashani-Sabet, Mohammed, Venna, Suraj, Nosrati, Mehdi, Rangel, Javier, Sucker, Antje, Egberts, Friederike, Baehner, Frederick L, Simko, Jeff, Leong, Stanley P L, Haqq, Chris, Hauschild, Axel, Schadendorf, Dirk, Miller, 3rd, James R, Sagebiel, Richard W

    Published in Clinical cancer research (15-11-2009)
    “…Purpose: To determine the prognostic significance of a multimarker assay incorporating expression levels of three molecular markers in primary cutaneous…”
    Get full text
    Journal Article
  6. 6

    Identifying Individuals at High Risk of Melanoma: A Practical Predictor of Absolute Risk by FEARS, Thomas R, GUERRY, Dupont, PFEIFFER, Ruth M, SAGEBIEL, Richard W, ELDER, David E, HALPERN, Allan, HOLLY, Elizabeth A, HARTGE, Patricia, TUCKER, Margaret A

    Published in Journal of clinical oncology (01-08-2006)
    “…We developed a model to estimate the 5-year absolute risk of melanoma to efficiently identify individuals at increased risk of melanoma for potential…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    Diet and Melanoma in a Case-Control Study by MILLEN, Amy E, TUCKER, Margaret A, HARTGE, Patricia, HALPERN, Allan, ELDER, David E, GUERRY, Dupont, HOLLY, Elizabeth A, SAGEBIEL, Richard W, POTISCHMAN, Nancy

    “…Background: Malignant melanoma has been one of the most rapidly increasing cancers within the United States with few modifiable risk factors. This study…”
    Get full text
    Journal Article
  10. 10

    A patient-centered methodology that improves the accuracy of prognostic predictions in cancer by Kashani-Sabet, Mohammed, Sagebiel, Richard W, Joensuu, Heikki, Miller, 3rd, James R

    Published in PloS one (27-02-2013)
    “…Individualized approaches to prognosis are crucial to effective management of cancer patients. We developed a methodology to assign individualized 5-year…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Tumor Vascularity in the Prognostic Assessment of Primary Cutaneous Melanoma by KASHANI-SABET, Mohammed, SAGEBIEL, Richard W, FERREIRA, Carlos M. M, NOSRATI, Mehdi, MILLER, James R

    Published in Journal of clinical oncology (01-04-2002)
    “…The vascular supply of the primary tumor is recognized to play an important role in the progression of a number of solid tumors. However, the role of tumor…”
    Get full text
    Journal Article
  13. 13

    Prognostic Significance of Nuclear Receptor Coactivator-3 Overexpression in Primary Cutaneous Melanoma by RANGEL, Javier, TORABIAN, Sima, SHAIKH, Ladan, NOSRATI, Mehdi, BAEHNER, Frederick L, HAQQ, Chris, LEONG, Stanley P. L, MILLER, James R, SAGEBIEL, Richard W, KASHANI-SABET, Mohammed

    Published in Journal of clinical oncology (01-10-2006)
    “…To assess the prognostic significance of nuclear receptor coactivator-3 (NCOA3) overexpression in primary cutaneous melanoma. NCOA3 expression was assessed…”
    Get full text
    Journal Article
  14. 14

    NF-κB in the Vascular Progression of Melanoma by KASHANI-SABET, Mohammed, SHAIKH, Laden, MILLER, James R, NOSRATI, Mehdi, FERREIRA, Carlos M. M, DEBS, Robert J, SAGEBIEL, Richard W

    Published in Journal of clinical oncology (15-02-2004)
    “…To examine a model of melanoma progression based on vascular factors and the role of NF-kappa B in the vascular progression of melanoma. A data set of 526…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Prospective Validation of Molecular Prognostic Markers in Cutaneous Melanoma: A Correlative Analysis of E1690 by Kashani-Sabet, Mohammed, Nosrati, Mehdi, Miller, 3rd, James R, Sagebiel, Richard W, Leong, Stanley P L, Lesniak, Andrew, Tong, Schuyler, Lee, Sandra J, Kirkwood, John M

    Published in Clinical cancer research (15-11-2017)
    “…To validate the prognostic impact of combined expression levels of three markers (SPP1, RGS1, and NCOA3) in melanoma specimens from patients enrolled in the…”
    Get full text
    Journal Article
  17. 17

    BPTF transduces MITF-driven prosurvival signals in melanoma cells by Dar, Altaf A., Majid, Shahana, Bezrookove, Vladimir, Phan, Binh, Ursu, Sarah, Nosrati, Mehdi, De Semir, David, Sagebiel, Richard W., Miller, James R., Debs, Robert, Cleaver, James E., Kashani-Sabet, Mohammed

    “…Microphthalmia-associated transcription factor (MITF) plays a critical and complex role in melanocyte transformation. Although several downstream targets of…”
    Get full text
    Journal Article
  18. 18

    Osteopontin as a molecular prognostic marker for melanoma by Rangel, Javier, Nosrati, Mehdi, Torabian, Sima, Shaikh, Ladan, Leong, Stanley P. L., Haqq, Chris, Miller, James R., Sagebiel, Richard W., Kashani‐Sabet, Mohammed

    Published in Cancer (01-01-2008)
    “…BACKGROUND. Osteopontin has been suggested as a marker of disease progression in patients with melanoma because of its overexpression in recent microarray…”
    Get full text
    Journal Article
  19. 19

    Novel Role for RGS1 in Melanoma Progression by RANGEL, Javier, NOSRATI, Mehdi, LEONG, Stanley P. L, HAQQ, Chris, MILLER, James R, SAGEBIEL, Richard W, KASHANI-SABET, Mohammed

    Published in The American journal of surgical pathology (01-08-2008)
    “…RGS1 (regulator of G protein signaling 1) encodes a member of the regulator of G protein family. Recently, RGS1 was found to be overexpressed in gene…”
    Get full text
    Journal Article
  20. 20

    Prognostic Impact of PHIP Copy Number in Melanoma: Linkage to Ulceration by Bezrookove, Vladimir, De Semir, David, Nosrati, Mehdi, Tong, Schuyler, Wu, Clayton, Thummala, Suresh, Dar, Altaf A., Leong, Stanley P.L., Cleaver, James E., Sagebiel, Richard W., Miller, James R., Kashani-Sabet, Mohammed

    Published in Journal of investigative dermatology (01-03-2014)
    “…Ulceration is an important prognostic factor in melanoma whose biologic basis is poorly understood. Here we assessed the prognostic impact of pleckstrin…”
    Get full text
    Journal Article